CLINICAL_TRIALS
trial_result
· 2021-12-01
Clinical Trial Update: Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas [Phase 2]
Summary
Phase 2 trial of axitinib in Neurofibromatosis Type 2 with progressive vestibular schwannomas completed; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NYU Langone Health | Conditions: Neurofibromatosis Type 2, Vestibular Schwannomas | Phase 2 | Status: COMPLETED | Results posted: 2021-12-01